188 related articles for article (PubMed ID: 8588029)
1. [Overview of MRI contrast media. The case of endorem].
Duroux M
Radiologe; 1995 Nov; 35(11 Suppl 2):S247-8. PubMed ID: 8588029
[No Abstract] [Full Text] [Related]
2. Liver imaging with ferumoxides (Feridex): fundamentals, controversies, and practical aspects.
Clément O; Siauve N; Cuénod CA; Frija G
Top Magn Reson Imaging; 1998 Jun; 9(3):167-82. PubMed ID: 9621405
[TBL] [Abstract][Full Text] [Related]
3. Real enhancement or merely increased contrast?
Chen JH
AJR Am J Roentgenol; 1997 Jan; 168(1):279-80. PubMed ID: 8976963
[No Abstract] [Full Text] [Related]
4. Clinical evaluation of ultrasmall superparamagnetic iron oxide particles for liver imaging.
Saini S; Edelman RR; Li W; Petersein J; Hahn PF
Acad Radiol; 1996 Aug; 3 Suppl 2():S409-12. PubMed ID: 8796616
[No Abstract] [Full Text] [Related]
5. [Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium endorem].
Vogl TJ; Hammerstingl R; Keck H; Felix R
Radiologe; 1995 Nov; 35(11 Suppl 2):S258-66. PubMed ID: 8588032
[TBL] [Abstract][Full Text] [Related]
6. [The endorem tolerance profile].
Laniado M; Chachuat A
Radiologe; 1995 Nov; 35(11 Suppl 2):S266-70. PubMed ID: 8588033
[TBL] [Abstract][Full Text] [Related]
7. Liver. II: Iron oxide-based reticuloendothelial contrast agents for MR imaging. Clinical review.
Petersein J; Saini S; Weissleder R
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):53-60. PubMed ID: 8673716
[TBL] [Abstract][Full Text] [Related]
8. European clinical experience with Endorem. A new contrast agent for liver MRI in 1000 patients.
Chachuat A; Bonnemain B
Radiologe; 1995 Nov; 35(11 Suppl 2):S274-6. PubMed ID: 8588035
[No Abstract] [Full Text] [Related]
9. Evaluation of the time window for Resovist-enhanced T2-weighted MRI of the liver.
Reimer P; Müller M; Marx C; Balzer T
Acad Radiol; 2002 Aug; 9 Suppl 2():S336-8. PubMed ID: 12188267
[No Abstract] [Full Text] [Related]
10. Superparamagnetic nanoparticles as blood-pool contrast agents. Contribution to MRI preclinical investigations.
Benderbous S; Bonnemain B
Radiologe; 1995 Nov; 35(11 Suppl 2):S248-52. PubMed ID: 8588030
[No Abstract] [Full Text] [Related]
11. [Detection of liver tumors].
Rummeny EJ; Reimer P; Daldrup H; Peters PE
Radiologe; 1995 Nov; 35(11 Suppl 2):S252-8. PubMed ID: 8588031
[TBL] [Abstract][Full Text] [Related]
12. [MR contrast agent: resovist (SH U 555A)].
Nakajima H; Ichikawa T
Nihon Rinsho; 2001 Oct; 59 Suppl 6():328-32. PubMed ID: 11761967
[No Abstract] [Full Text] [Related]
13. Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging.
Briley-Saebo K; Bjørnerud A; Grant D; Ahlstrom H; Berg T; Kindberg GM
Cell Tissue Res; 2004 Jun; 316(3):315-23. PubMed ID: 15103550
[TBL] [Abstract][Full Text] [Related]
14. Focal nodular hyperplasia of the liver: usefulness of superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Okada T; Sasaki F; Kamiyama T; Nakagawa T; Nakanishi K; Kobayashi R; Itoh T; Ota S; Todo S
J Pediatr Surg; 2005 Mar; 40(3):E21-5. PubMed ID: 15793708
[TBL] [Abstract][Full Text] [Related]
15. [Detection of liver lesions: magnetic resonance tomography using superparamagnetic iron particles (AMI-25, endorem) as a contrast medium in comparison with ultrasound diagnosis, computerized tomography and CT portography].
Pleger B; Beyer HK; Laufer U
Rontgenpraxis; 2001; 53(6):245-9. PubMed ID: 11402872
[No Abstract] [Full Text] [Related]
16. Combined use of MR contrast agents for evaluating liver disease.
Ward J; Robinson PJ
Magn Reson Imaging Clin N Am; 2001 Nov; 9(4):767-802, vi. PubMed ID: 11694437
[TBL] [Abstract][Full Text] [Related]
17. [Organ specific MRI contrast media in general practice].
Schima W
Wien Med Wochenschr Suppl; 2002; (113):8-11. PubMed ID: 12621828
[TBL] [Abstract][Full Text] [Related]
18. [Focal intrahepatic siderosis, diagnostic pitfall, iatrogenic image].
Arteaga C; Raillat A; Salamand P; Debonne JM; Bonnet D; Martet G; Veuillet MO; Battini-Nouzille A; Briant JF
J Radiol; 1998 Feb; 79(2):157-8. PubMed ID: 9757234
[No Abstract] [Full Text] [Related]
19. State of the art in diagnostic liver imaging.
Lamprecht A; Wagner B
Eur Radiol; 2004 Jan; 14 Suppl 1():C2-3. PubMed ID: 15113057
[No Abstract] [Full Text] [Related]
20. [Magnetic resonance imaging of the liver: what kind of contrast agents?].
De Gaspari A; De Cobelli F; Del Maschio A
Radiol Med; 2001 Sep; 102(3):109-21. PubMed ID: 11677451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
